Jushi (OTCMKTS:JUSHF – Get Free Report) is one of 53 public companies in the “Medicinals & botanicals” industry, but how does it compare to its competitors? We will compare Jushi to related businesses based on the strength of its analyst recommendations, earnings, valuation, profitability, institutional ownership, risk and dividends.
Volatility and Risk
Jushi has a beta of -0.16, suggesting that its stock price is 116% less volatile than the S&P 500. Comparatively, Jushi’s competitors have a beta of 1.32, suggesting that their average stock price is 32% more volatile than the S&P 500.
Analyst Ratings
This is a summary of recent recommendations for Jushi and its competitors, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Jushi | 0 | 2 | 0 | 0 | 2.00 |
Jushi Competitors | 246 | 546 | 909 | 66 | 2.45 |
Profitability
This table compares Jushi and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Jushi | -24.16% | -320.66% | -10.31% |
Jushi Competitors | -48.57% | -31.53% | -7.91% |
Insider & Institutional Ownership
21.7% of Jushi shares are held by institutional investors. Comparatively, 16.2% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 21.0% of Jushi shares are held by company insiders. Comparatively, 22.5% of shares of all “Medicinals & botanicals” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares Jushi and its competitors revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Jushi | $269.45 million | -$65.10 million | -2.13 |
Jushi Competitors | $325.84 million | -$162.92 million | -10.08 |
Jushi’s competitors have higher revenue, but lower earnings than Jushi. Jushi is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Summary
Jushi competitors beat Jushi on 9 of the 13 factors compared.
Jushi Company Profile
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.
Receive News & Ratings for Jushi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jushi and related companies with MarketBeat.com's FREE daily email newsletter.